A compound called isoquinolinone 2.1 has been identified as a potential drug component that can treat people with chronic intractable itch. The compound can do so without triggering adverse side effects.
Scratch No More: Scripps Researchers Discover Promising Treatment For Chronic Itch With No Side Effects
Tech Times - 1 Oct 2015 16:04
A compound called isoquinolinone 2.1 has been identified as a potential drug component that can treat people with chronic intractable itch. The compound can do so without triggering adverse side effects.
Share this Article
Recommended